{"pub": "investing.com", "url": "https://ng.investing.com/news/stock-market-news/update-1ftse-100-on-track-for-fourth-session-of-gains-72711", "downloaded_at": "2019-10-28 00:34:52.549328+00:00", "title": "UPDATE 1-FTSE 100 on track for fourth session of gains", "language": "en", "text": "\u00a9 Reuters. UPDATE 1-FTSE 100 on track for fourth session of gains\n\n* FTSE 100 up 0.7%, FTSE 250 up 0.2%\n\n* AstraZeneca biggest boost to main index\n\n* RBS slides after reporting Q3 loss\n\n(Adds company news items, analyst comments, updates share\n\nprices)\n\nBy Muvija M and Shashwat Awasthi\n\nOct 24 (Reuters) - London's FTSE 100 rose on Thursday along\n\nwith its European counterparts, helped by strong French\n\nmanufacturing data and gains in AstraZeneca after a 2019\n\nforecast upgrade.\n\nThe blue-chip index climbed 0.7% to a near one-month\n\nhigh by 0730 GMT, on course for its fourth session of gains. A\n\ndip in sterling limited the FTSE 250 to a 0.2% gain.\n\nAfter rising to session highs following data from France,\n\nthe main bourse eased slightly after another survey showed\n\nemployment in Germany's private sector fell for the first time\n\nin six years in October. The conflicting data come at a time of existing fears over\n\nglobal economic growth, as multiple unfavourable events\n\nincluding the U.S.-China trade tussle and Brexit play out.\n\nIn the past two weeks UK shares have been volatile with\n\nmajor Brexit developments including Prime Minister Boris Johnson\n\nstriking a new Brexit deal with the European bloc and lawmakers\n\nat home forcing his hand into asking for another extension to\n\nthe divorce.\n\n'U.S.-CHINA AND BREXIT IN LIMBO'\n\nThe FTSE 100, whose components rake in more than two-thirds\n\nof their earnings in U.S. dollars, is on course for its best\n\nweekly gain since early June, as uncertainties over the course\n\nof UK's EU departure have dented the value of sterling.\n\nAstraZeneca gained 3%, its biggest one-day rise in\n\nthree months, after the pharmaceutical giant raised its annual\n\nproduct sales forecast for the second time this year.\n\nAnalytics and decision tools provider Relx and\n\nindustrial software company Aveva added 2.5% each\n\nfollowing trading updates.\n\n\"There's not been a huge catalyst for markets this week.\n\nEarnings are largely topping beaten-down estimates. U.S.-China\n\nand Brexit are in limbo,\" Markets.com analyst Neil Wilson said.\n\nOn the other end of the spectrum was Royal Bank of Scotland\n\nthat skidded 3% as it swung to a third-quarter loss due\n\nto a fresh 900 million pound provision to settle mis-selling\n\nclaims.\n\nA notable mid-cap performer was Kaz Minerals that\n\njumped 7% after record third-quarter copper production as it\n\nramped up operations at its biggest mines in Kazakhstan.\n\nWoodford Patient Capital Trust , formerly run by\n\nhigh-profile money manager Neil Woodford, jumped 22% as the\n\ncompany appointed asset manager Schroders as its new\n\nportfolio manager.", "description": "UPDATE 1-FTSE 100 on track for fourth session of gains", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB9M0BY_L.jpg", "published_at": "2019-10-24"}